Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
5.120 EUR | +0.39% |
|
-4.66% | -6.23% |
02:42am | Futures Slide; Mib Drops Over 200 Points | AN |
Jun. 11 | Mib down slightly; Azimut takes the lead | AN |
Projected Income Statement: Garofalo Health Care S.p.A.
Annual
Quarterly
Halfyear
Annual
Quarterly
Halfyear
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 210.8 | 283.7 | 322.6 | 368.7 | 470.7 | 481 | 489 | 498 |
Change | - | 34.54% | 13.71% | 14.3% | 27.67% | 2.19% | 1.66% | 1.84% |
EBITDA 1 | 34 | 53.1 | 58.6 | 67.1 | 78.5 | 82.6 | 86.7 | 89 |
Change | - | 56.18% | 10.36% | 14.51% | 16.99% | 5.22% | 4.96% | 2.65% |
EBIT 1 | 15.49 | 28.23 | 31.66 | 39.23 | 44.13 | 50.4 | 53.3 | 54.8 |
Change | - | 82.26% | 12.16% | 23.89% | 12.48% | 14.22% | 5.75% | 2.81% |
Interest Paid 1 | -2.758 | -4.512 | -4.551 | - | -14.76 | -13.4 | -13.2 | -13 |
Earnings before Tax (EBT) 1 | 13.02 | 23.99 | 27.37 | 28.93 | 30.69 | 37 | 40.1 | 41.8 |
Change | - | 84.21% | 14.1% | 5.7% | 6.07% | 20.58% | 8.38% | 4.24% |
Net income 1 | 11.78 | 18.83 | 21.43 | 20.8 | 21.7 | 26.6 | 28.9 | 30.1 |
Change | - | 59.87% | 13.76% | -2.93% | 4.34% | 22.57% | 8.65% | 4.15% |
Announcement Date | 3/16/21 | 3/16/22 | 3/16/23 | 3/14/24 | 3/14/25 | - | - | - |
1EUR in Million
Estimates
Forecast Balance Sheet: Garofalo Health Care S.p.A.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 97.7 | 142 | 145 | 206 | 205 | 192 | 176 | 143 |
Change | - | 45.34% | 2.11% | 42.07% | -0.49% | -6.12% | -8.33% | -18.75% |
Announcement Date | 3/16/21 | 3/16/22 | 3/16/23 | 3/14/24 | 3/14/25 | - | - | - |
1EUR in Million
Estimates
Cash Flow Forecast: Garofalo Health Care S.p.A.
Fiscal Period: December | 2020 | 2021 | 2022 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
CAPEX 1 | - | 24.67 | 14.97 | 21.59 | 36 | 35 | 19.9 |
Change | - | - | -39.32% | - | 66.71% | -2.78% | -43.14% |
Free Cash Flow (FCF) 1 | 4.315 | 11.65 | 28.9 | 13.4 | 31.7 | 39.1 | 41.6 |
Change | - | 169.9% | 148.16% | - | 136.57% | 23.34% | 6.39% |
Announcement Date | 3/16/21 | 3/16/22 | 3/16/23 | 3/14/25 | - | - | - |
1EUR in Million
Estimates
Forecast Financial Ratios: Garofalo Health Care S.p.A.
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|---|
Profitability | |||||||||
EBITDA Margin (%) | - | 16.13% | 18.72% | 18.17% | 18.2% | 16.68% | 17.17% | 17.73% | 17.87% |
EBIT Margin (%) | - | 7.35% | 9.95% | 9.82% | 10.64% | 9.37% | 10.48% | 10.9% | 11% |
EBT Margin (%) | - | 6.18% | 8.46% | 8.49% | 7.85% | 6.52% | 7.69% | 8.2% | 8.39% |
Net margin (%) | - | 5.59% | 6.64% | 6.64% | 5.64% | 4.61% | 5.53% | 5.91% | 6.04% |
FCF margin (%) | - | 2.05% | 4.11% | 8.96% | - | 2.85% | 6.59% | 8% | 8.35% |
FCF / Net Income (%) | - | 36.63% | 61.83% | 134.89% | - | 61.75% | 119.17% | 135.29% | 138.21% |
Profitability | |||||||||
ROA | 3.88% | 2.89% | 3.89% | 3.92% | 3.8% | 3.77% | - | - | - |
ROE | 6.96% | 5.96% | 8.12% | 7.94% | 7.2% | 6.89% | - | - | - |
Financial Health | |||||||||
Leverage (Debt/EBITDA) | - | 2.87x | 2.68x | 2.47x | 3.07x | 2.61x | 2.32x | 2.03x | 1.61x |
Debt / Free cash flow | - | 22.64x | 12.23x | 5.02x | - | 15.26x | 6.06x | 4.5x | 3.44x |
Capital Intensity | |||||||||
CAPEX / Current Assets (%) | - | - | 8.7% | 4.64% | - | 4.59% | 7.48% | 7.16% | 4% |
CAPEX / EBITDA (%) | - | - | 46.46% | 25.54% | - | 27.51% | 43.58% | 40.37% | 22.36% |
CAPEX / FCF (%) | - | - | 211.82% | 51.79% | - | 161.15% | 113.56% | 89.51% | 47.84% |
Items per share | |||||||||
Cash flow per share 1 | - | - | 0.407 | 0.4934 | - | - | - | - | - |
Change | - | - | - | 21.26% | - | - | - | - | - |
Dividend per Share 1 | - | - | - | - | - | - | 0.09 | 0.097 | 0.102 |
Change | - | - | - | - | - | - | - | 7.78% | 5.15% |
Book Value Per Share 1 | - | 2.262 | 2.919 | 3.139 | 3.375 | - | 3.8 | 4 | 4.3 |
Change | - | - | 29.03% | 7.55% | 7.53% | - | - | 5.26% | 7.5% |
EPS 1 | - | 0.14 | 0.21 | 0.24 | 0.18 | 0.24 | 0.3 | 0.325 | 0.339 |
Change | - | - | 50% | 14.29% | -25% | 33.33% | 25% | 8.33% | 4.31% |
Nbr of stocks (in thousands) | - | 81,773 | 89,298 | 88,966 | 88,578 | 88,563 | 88,466 | 88,466 | 88,466 |
Announcement Date | - | 3/16/21 | 3/16/22 | 3/16/23 | 3/14/24 | 3/14/25 | - | - | - |
1EUR
Estimates
2025 * | 2026 * | |
---|---|---|
P/E ratio | 17x | 15.7x |
PBR | 1.34x | 1.28x |
EV / Sales | 1.34x | 1.28x |
Yield | 1.76% | 1.9% |
More valuation ratios
* Estimated data
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
5.100EUR
Average target price
6.500EUR
Spread / Average Target
+27.45%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GHC Stock
- Financials Garofalo Health Care S.p.A.
Select your edition
All financial news and data tailored to specific country editions